Skip to main content

Table 2 Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)

From: Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India

Days

Subjects at risk

Lost to follow up

Therapeutic failure

IR

CITF

0

125

0

0

1.00

0

2

125

0

0

1.00

0

3

125

0

1

0.99

0.01

7

124

3

0

0.99

0.01

14

121

0

0

0.99

0.01

21

121

0

0

0.99

0.01

28

121

0

0

0.99

0.01

  1. IR interval risk, CITF cumulative incidence of therapeutic failure.